Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science. 1995;270:475–80.PubMedCrossRef

Sokolic R, Kesserwan C, Candotti F. Recent advances in gene therapy for severe congenital immunodeficiency diseases. Curr Opin Hematol. 2008;15:375–80. doi:10.​1097/​MOH.​0b013e328302c807​.PubMedCentralPubMedCrossRef

Van de Water TR, Staecker H, Halterman MW, Federoff HJ. Gene therapy in the inner ear. Mechanisms and clinical implications. Ann N Y Acad Sci. 1999;884:345–60.PubMedCrossRef

Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swidershi DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11:271–6.PubMedCrossRef

Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–11.PubMedCrossRef

Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov. 2012;11:125–40. doi:10.​1038/​nrd3625.PubMed

Lentz JJ, Jodelka FM, Hinrich AJ, McCaffrey KE, Farris HE, Spalitta MJ, et al. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med. 2013;19:345–50. doi:10.​1038/​nm.​3106.PubMedCentralPubMedCrossRef

Miwa T, Minoda R, Ise M, Yamada T, Yumoto E. Mouse otocyst transuterine gene transfer restores hearing in mice with connexin 30 deletion-associated hearing loss. Mol Ther. 2013;21:1142–50. doi:10.​1038/​mt.​2013.​62.PubMedCentralPubMedCrossRef

Maeda Y, Fukushima K, Nishizaki K, Smith RJ. In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet. 2005;14:1641–50.PubMedCrossRef

Fukui H, Raphael Y. Gene therapy for the inner ear. Hear Res. 2013;297:99–105. doi:10.​1016/​j.​heares.​2012.​11.​017.PubMedCentralPubMedCrossRef